Affinity Asset Advisors’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Affinity Asset Advisors's RVMD Position: Q3 2026 in Review
Affinity Asset Advisors reduced its Revolution Medicines (RVMD) stake by 10% in Q3 2026, selling an estimated $4.96M and leaving 225,000 shares worth $46.2M. The position accounts for 1.88% of the portfolio, ranked #17.
Affinity Asset Advisors first reported a position in RVMD in Q3 2025 and has held it in 5 quarters since. The position peaked at $46.8M in Q2 2026. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Affinity Asset Advisors held 225,000 shares of Revolution Medicines worth $46.2M as of Q3 2026.
- Affinity Asset Advisors sold 25,000 Revolution Medicines shares in Q3 2026, an estimated $4.96M.
- Revolution Medicines made up 1.88% of Affinity Asset Advisors's portfolio in Q3 2026, its #17 holding.
- Affinity Asset Advisors first reported a position in Revolution Medicines in Q3 2025 and has held it in 5 quarters since.
- Affinity Asset Advisors's Revolution Medicines position peaked at $46.8M in Q2 2026.
- 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.